Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Schizophrenia

Schizophrenia

Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...

Biological Causes of Schizophrenia

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.

Negative and Cognitive Symptoms of Schizophrenia

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Parenteral Nutrition: Amino Acids.

Nutrients·2017

Same author

Protein requirement in critical illness.

Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme·2016

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

Vitamin therapy in schizophrenia.

Leonard John Hoffer¹

¹McGill University, Lady Davis Institute for Medical Research, Jewish General Hospital,Montreal, Quebec, Canada. l.hoffa@mcgill.ca

The Israel Journal of Psychiatry and Related Sciences

|July 1, 2008

Summary

Certain vitamin deficiencies may worsen schizophrenia symptoms. Supplementing with high-dose vitamins could improve metabolic issues and potentially treat schizophrenia, warranting further clinical trials.

Area of Science:

Nutritional Psychiatry
Metabolic Psychiatry
Schizophrenia Research

Background:

Schizophrenia is a complex neurological disorder with limited treatment options.
Current treatments for schizophrenia primarily involve nonspecific antipsychotic and anti-seizure medications.
The role of nutritional factors in schizophrenia pathogenesis remains under investigation.

Purpose of the Study:

To review evidence linking vitamin deficiencies to exacerbated schizophrenia symptoms.
To explore the potential of high-dose vitamin supplementation in addressing metabolic abnormalities associated with schizophrenia.
To discuss the historical context and future directions for nutrient-based schizophrenia therapies.

Main Methods:

Literature review of studies on vitamin deficiencies and schizophrenia.

More Related Videos

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Related Experiment Videos

Last Updated: Jul 4, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Analysis of research on the efficacy of high-dose vitamin therapy for schizophrenia.

Historical overview of orthomolecular psychiatry.

Main Results:

Evidence suggests that specific vitamin deficiencies can worsen schizophrenia symptoms.
High-dose vitamin supplementation shows potential for improving metabolic dysfunctions linked to schizophrenia.
Orthomolecular psychiatry, a vitamin-based approach, has a controversial history but offers insights.

Conclusions:

Nutritional interventions, particularly vitamin supplementation, may offer a novel therapeutic avenue for schizophrenia.
Further research involving carefully designed clinical trials of nutrient combinations is advocated.
Personalized treatment strategies targeting metabolic pathways could advance schizophrenia care.